top of page

Media & Press

AztronMedtech-Logo-FullColor-Light-NavyBG_edited.jpg

Oct 2025

Aztron Medtech and Lovell Government Services Secure FSS, ECAT and GSA Listings, Expanding U.S. Government Access to TendMIN™ Achilles Tendon Repair System

Aztron's TendMIN™ Minimally Invasive Achilles Repair System, is now listed on the Federal Supply Schedule (FSS), the Defense Logistics Agency’s Electronic Catalog (ECAT) and the GSA Advantage platform. These listings allow federal health systems, including the Department of Defense (DoD) and Veterans Affairs (VA) medical facilities, to purchase TendMIN™ directly through established government procurement channels.

50TH CASE 2.jpg

Aug 2025

Completes 50th U.S. TendMIN™ Procedure in Minimally Invasive Achilles Repair, Signaling Strong Early Adoption

Aztron Medtech is proud to announce that Aztron’s TendMIN™ system has now been used in 50 minimally invasive Achilles tendon repairs across 15 U.S. hospitals and surgical centers — including multiple leading academic institutions — within just 4 months of pilot launch!

 

This milestone procedure was performed by Dr. David Garras, a board-certified foot and ankle surgeon who has been instrumental in bringing TendMIN™ into clinical practice.

WhatsApp Image 2025-08-13 at 00.01.59.jpeg

Jul 2025

Aztron Medtech Achieves Major Milestones: FDA Listed and $2.5M Seed+ Funding Raised

Astron Medtech has received FDA listed for its TendMIN™ telescoping-needle, designed for minimally invasive Achilles tendon repair.

 

With the company’s $2.5 million Seed + funding, accelerating commercialization of the TendMIN™ system and expanding access to advanced MIS Achilles tendon repair.

AztronMedtech-Logo-FullColor-Light-NavyB

Jan 2025

Astron Medtech is Now Aztron Medtech!

We are excited to announce our rebrand to Aztron Medtech, reflecting our commitment to innovation in orthopedic soft tissue repair. While our name has changed, our mission remains the same—to advance minimally invasive surgical solutions and improve patient outcomes.

Thank you for your continued support as we enter this new chapter! 

Oct 2024

First In Human Completed!

Astron Medtech announces First TendMIN™ minimally invasive Achilles tendon repair in the United States.

June 2023

Astron Selected for MedTech Innovator Asia Pacific 2023

Astron is proud to be among 24 innovative companies selected for the MedTech Innovator Asia Pacific 2023 Program.

915d046ec4c5dd5dadd3c95f48d7b191.png

August 2022

MeetTapei, leading entrepreneurship platform, features and interviews Astron MedTech

Meet covers Astron MedTech's inspirations, technology, and future plans in great detail.

S__17580168.jpg

July 2022

Astron MedTech receives Top Prize at SelectUSA Tech 2022

Astron MedTech was chosen out of 16 finalists in the MedTech Software category in Maryland!

selectusa.jpeg

December 2021

The Ministry of Economic Affairs announces Astron MedTech's Top Award in SelectUSA Tech 

The Ministry of Economic Affairs issued a press release of Astron MedTech's strong performance in SelectUSA Investment Summit.

FITI.jpg

December 2021

The Ministry of Science and Technology awards
NT$1 million to Astron MedTech 

As one of three finalists, Astron MedTech wins the "Entrepreneurial Excellence Award" as part of the Entrepreneurship Incentive Program.

© 2025 Aztron Medtech Corporation. All rights reserved.

bottom of page